Skip to main content
SpringerLink
Log in

Alternative Therapies for Chronic Refractory Coronary Artery Disease

  • Chapter
  • First Online:
Coronary Artery Disease

  • 1231 Accesses

Abstract

Complementary and alternative medicine (CAM) appears to be well embedded into the American culture [1]. This phenomenon, coupled with the explosive growth of the Internet, has provided patients and consumers dramatically increased access to information about a variety of alternative treatments that were relatively unheard of a decade or two ago. Most studies suggest that at least 40% of US adults have used some form of CAM in the past year. Interest in CAM is particularly high in those patients who are facing chronic illnesses, and patients with chronic coronary artery disease (CAD) are no exception.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Barnes P, Powell-Griner E, McFann K, et al. CDC Advance Data Report #343. Complementary and alternative medicine use among adults: United States, 2002. May 27 2004. http://nccam.nih.gov/news/camsurvey.htm. Accessed 15 Jun 2005.

  2. Eisenberg DM, Kessler RC, Foster C, et al. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med. 1993;328:246–52.

    Article  PubMed  CAS  Google Scholar 

  3. Wetzel MS, Eisenberg DM, Kaptchuk TJ. Courses involving complementary and alternative medicine at US medical schools. JAMA. 1998;280(9):784–7.

    Article  PubMed  CAS  Google Scholar 

  4. Brokaw JJ, Tunnicliff G, Raess BU, et al. The teaching of complementary and alternative medicine in US medical schools: a survey of course directors. Acad Med. 2002;77(9):876–81.

    Article  PubMed  Google Scholar 

  5. Acupuncture. NIH consensus statement 1997 Nov 3–5; 15(5):1–34. http://odp.od.nih.gov/consensus/cons/107/107_statement.htm. Accessed 15 Jun 2005.

  6. Straus SE. Complementary and alternative medicine: challenges and opportunities for American medicine. Acad Med. 2000;75(6):572–3.

    Article  PubMed  CAS  Google Scholar 

  7. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA. 1998;280:1569–75.

    Article  PubMed  CAS  Google Scholar 

  8. Barnes PM, Bloom B, Nahin RL, Complementary and Alternative medicine use among adults and children: United States 2007 National Health statistics report; No 12. hyattsville, MD National Center for Health Statistics. 2008.

    Article  PubMed  CAS  Google Scholar 

  9. Richardson MA, Sanders T, Palmer JL, et al. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol. 2000;18(13): 2505–14.

    PubMed  CAS  Google Scholar 

  10. Anonymous. What is complementary and alternative medicine (CAM)?. 2005. http://nccam.nih.gov/health/whatiscam. Accessed 15 Jun 2005.

  11. Quan H, Ghali WA, Verhoef MJ, et al. Use of chelation therapy after coronary angiography. Am J Med. 2001;111:686–91.

    Article  PubMed  CAS  Google Scholar 

  12. Anand A, Evans MF. Does chelation therapy work for ischemic heart disease? Can Fam Physician. 2003;49:307–9.

    PubMed  Google Scholar 

  13. Grier MT, Meyers DG. So much writing, so little science: a review of 37 years of literature on edetate sodium chelation therapy. Ann Pharmacother. 1993;27:1504–9.

    PubMed  CAS  Google Scholar 

  14. University of Maryland Medical Center, Complementary Medicine Program, Ethylenediaminetetraacetic Acid (EDTA). 2005. http://www.umm.edu/altmed/ConsSupplements/Ethyl­en­ediaminetetraaceticAcidEDTAcs.html. Accessed 15 Jun 2005.

  15. Green S. chelation therapy: unproven claims and unsound. 2005. http://www.quackwatch.org/01QuackeryRelatedTopics/chelation.html. Accessed 15 Jun 2005.

  16. McCord JM, Day Jr ED. Superoxide-dependent production of hydroxyl radical catalyzed by iron-EDTA complex. FEBS Lett. 1978;233:1206–8.

    Google Scholar 

  17. Clarke NE, Clarke CN, Mosher RE. Treatment of angina pectoris with disodium ethylene diamine tetraacetic acid. Am J Med Sci. 1956;232:654–6.

    Article  PubMed  CAS  Google Scholar 

  18. Meltzer LE, Ural E, Kitchell JR. The treatment of coronary artery heart disease with disodium EDTA. In: Seven M, editor. Metal-binding in medicine. Philadelphia: Lippincott; 1960.

    Google Scholar 

  19. Kitchell JR. The treatment of coronary artery disease with disodium EDTA: a reappraisal. Am J Cardiol. 1963;11:501–6.

    Article  PubMed  CAS  Google Scholar 

  20. Guldager B, Jelnes R, Jorgensen SJ, et al. EDTA treatment of intermittent claudication: a double-blind, placebo-controlled study. J Intern Med. 1992;231:261–7.

    Article  PubMed  CAS  Google Scholar 

  21. Chappel L, Stahl J. The correlation between EDTA chelation therapy and improvement in cardiovascular function: a meta-analysis. J Adv Med. 1993;6:139–60.

    Google Scholar 

  22. Chappell L, Stahl J, Evans R. EDTA chelation therapy for vascular disease: a meta-analysis using unpublished data. J Adv Med. 1994;7:131–42.

    Google Scholar 

  23. Margolis S. Chelation therapy is ineffective for treatment of peripheral vascular disease. Altern Ther Health Med. 1995;1(2):53–7.

    PubMed  CAS  Google Scholar 

  24. van Rij AM, Solomon C, Packer SGK, et al. Chelation therapy for intermittent claudication. A double-blind, randomized, controlled trial. Circulation. 1994;90:1194–9.

    PubMed  Google Scholar 

  25. Green DJ, O’Driscoll JG, Maiorana A, et al. Effects of chelation with EDTA and Vitamin B therapy on nitric oxide-related endothelial vasodilator function. Clin Exp Pharmacol Physiol. 1999;26:853–6.

    Article  PubMed  CAS  Google Scholar 

  26. Knudtson ML, Wyse DG, Galbraith PD, et al. Chelation therapy for ischemic heart disease: a randomized controlled trial. JAMA. 2002;287:481–6.

    Article  PubMed  CAS  Google Scholar 

  27. Anderson TJ, Hubacek J, Wyse DG, et al. Effect of chelation therapy on endothelial function in patients with coronary artery disease: PATCH Substudy. J Am Coll Cardiol. 2003;41:420–5.

    Article  PubMed  CAS  Google Scholar 

  28. Ernst E. Chelation therapy for coronary heart disease: an overview of all clinical investigations. Am Heart J. 2000;140:139–41.

    Article  PubMed  CAS  Google Scholar 

  29. Villarruz MV, Dans A, Tan F. Chelation therapy for ­atherosclerotic cardiovascular disease (Cochrane Review). In: The Cochrane Library, Issue 1, 2005. Villarruz MV, Dans A, Tan F. Cochrane Database Syst Rev. 2002;(4):CD002785. Review. PMID: 12519577 http://Chelationtherapyforatheroscleroticcardiovasculardisease

  30. Chelation Therapy Study. 2005. http://nccam.nih.gov/chelation/. Accessed 15 Jun 2005.

  31. McKevoy GK, editor. AHFS drug information. Bethesda: American Society of Health-System Pharmacists; 1998.

    Google Scholar 

  32. Grebe HB, Gregory PJ. Inhibition of warfarin anticoagulation associated with chelation therapy. Pharmacotherapy. 2002;22(8):1067–9.

    Article  PubMed  Google Scholar 

  33. Prabha A, Shetty M, Thomas J, et al. Chelation therapy for coronary heart disease. Am Heart J. 2002;144(5):E10.

    Article  PubMed  Google Scholar 

  34. Ballegaard S, Jensen G, Pedersen F, et al. Acupuncture in severe, stable angina pectoris: a randomized trial. Acta Med Scand. 1986;220(4):307–13.

    Article  PubMed  CAS  Google Scholar 

  35. Ballegaard S, Pedersen F, Pietersen A, et al. Effects of acupuncture in moderate, stable angina pectoris: a controlled study. J Intern Med. 1990;227(1):25–30.

    Article  PubMed  CAS  Google Scholar 

  36. Richter A, Herlitz J, Hjalmarson A. Effect of acupuncture in patients with angina pectoris. Eur Heart J. 1991;12(2):175–8.

    PubMed  CAS  Google Scholar 

  37. Ballegaard S, Meyer CN, Trojaborg W. Acupuncture in angina pectoris: does acupuncture have a specific effect? J Intern Med. 1991;229(4):357–62.

    Article  PubMed  CAS  Google Scholar 

  38. Ballegaard S, Muteki T, Harada H, et al. Modulatory effect of acupuncture on the cardiovascular system: a cross-over study. Acupunct Electrother Res. 1993;18(2):103–15.

    PubMed  CAS  Google Scholar 

  39. Ballegaard S, Karpatschoff B, Holck JA, et al. Acupuncture in angina pectoris: do psycho-social and neurophysiological factors relate to the effect? Acupunct Electrother Res. 1995;20(2):101–16.

    PubMed  CAS  Google Scholar 

  40. Yan H, Ke Y, Shu B. Angiographic observation of ­immediate effect of electric pulse stimulation at Zhiyang point on coronary artery. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1998;18(6):330–2, Chinese.

    PubMed  CAS  Google Scholar 

  41. Kurono Y, Egawa M, Yano T, et al. The effect of acupuncture on the coronary arteries as evaluated by coronary angiography: a preliminary report. Am J Chin Med. 2002;30(2–3):387–96.

    PubMed  CAS  Google Scholar 

  42. Shi X, Wang ZP, Liu KX. Effect of acupuncture on heart rate variability in coronary heart disease patients. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1995;15(9):536–8.

    PubMed  CAS  Google Scholar 

  43. Li L, Chen H, Xi Y, et al. Comparative observation on effect of electric acupuncture of neiguan (P 6) at chen time versus xu time on left ventricular function in patients with coronary heart disease. J Tradit Chin Med. 1994;14(4):262–5.

    PubMed  CAS  Google Scholar 

  44. Ho FM, Huang PJ, Lo HM, et al. Effect of acupuncture at nei-kuan on left ventricular function in patients with coronary artery disease. Am J Chin Med. 1999;27(2):149–56.

    Article  PubMed  CAS  Google Scholar 

  45. Ballegaard S, Johannessen A, Karpatschof B, et al. Addition of acupuncture and self-care education in the treatment of patients with severe angina pectoris may be cost beneficial: an open, prospective study. J Altern Complement Med. 1999;5(5):405–13.

    Article  PubMed  CAS  Google Scholar 

  46. Ballegaard S, Norrelund S, Smith DF. Cost-benefit of combined use of acupuncture, Shiatsu and lifestyle adjustment for treatment of patients with severe angina pectoris. Acupunct Electrother Res. 1996;21(3–4):187–97.

    PubMed  CAS  Google Scholar 

  47. Meng J. The effects of acupuncture in treatment of coronary heart diseases. J Tradit Chin Med. 2004;24(1):16–9.

    PubMed  Google Scholar 

  48. Hermann DD. Naturoceutical agents in the management of cardiovascular disease. Am J Cardiovasc Drugs. 2002;2(3):173–96.

    Article  PubMed  CAS  Google Scholar 

  49. Hermann DD, Kuiper JJ, Shabetai R, et al. Herbal, megavitamin and nutritional supplement use is very common in heart failure patient populations. J Am Coll Cardiol. 1999;33:201A.

    Google Scholar 

  50. Dietary Supplement Health and Education Act of 1994 Public Law 103–417 103rd Congress. 2005. http://www.fda.gov/opacom/laws/dshea.html. Accessed 15 Jun 2005.

  51. Langlois M, Duprez D, Delanghe J, et al. Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis. Circulation. 2001;103:1863–8.

    PubMed  CAS  Google Scholar 

  52. Klipstein-Grobusch K, den Breeijen J, Grobbee D, et al. Dietary antioxidants and peripheral arterial disease: the Rotterdam Study. Am J Epidemiol. 2001;154:145–9.

    Article  PubMed  CAS  Google Scholar 

  53. Salonen JT, Nyyssönen K, Salonen R, et al. Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Intern Med. 2000;248:377–86.

    Article  PubMed  CAS  Google Scholar 

  54. Salonen R, Nyyssönen K, Kaikkonen J, et al. Six-year effect of vitamin E and vitamin C supplementation on atherosclerosis progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study. Circulation. 2003;107:947–53.

    Article  PubMed  CAS  Google Scholar 

  55. Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 1996;347:781–6.

    Article  PubMed  CAS  Google Scholar 

  56. Rapola JM, Virtamo J, Ripatti S, et al. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infraction. Lancet. 1997;349:1715–20.

    Article  PubMed  CAS  Google Scholar 

  57. Gissi-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI Prevenzione trial. Lancet. 1999;354:447–55.

    Article  Google Scholar 

  58. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:154–60.

    Article  PubMed  CAS  Google Scholar 

  59. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342(3):145–53.

    Article  PubMed  CAS  Google Scholar 

  60. Morris M, Evans D, Tangney C, et al. Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change. Am J Clin Nutr. 2005;81:508–14.

    PubMed  CAS  Google Scholar 

  61. Wagner KH, Kamal-Eldin A, Elmadfa I. Gamma-tocopherol—an underestimated vitamin? Ann Nutr Metab. 2004;48:169–88.

    Article  PubMed  CAS  Google Scholar 

  62. Tonstad S, Smerud K, Hrie L. A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins and plasma total homocysteine in hypercholesterolemic subjects. Am J Clin Nutr. 2002;76:78–84.

    PubMed  CAS  Google Scholar 

  63. Henkel. FDA. Soy: Health claims for soy protein, questions about other components. May-June 2000. Available at: http://vm.cfsan.fda.gov/~dms/fdsoypr.html#health. Accessed 15 Jun 2005.

  64. Dwivedi S, Jauhari R. Beneficial effects of Terminalia arjuna in coronary artery disease. Indian Heart J. 1997;49:507–10.

    PubMed  CAS  Google Scholar 

  65. Dwivedi S, Agarwal MP. Antianginal and cardioprotective effects of Terminalia arjuna, an indigenous drug, in coronary artery disease. J Assoc Physicians India. 1994;42:287–9.

    PubMed  CAS  Google Scholar 

  66. Yu CM et al. Chinese herbs and warfarin potentiation by Danshen. J Intern Med. 1997;241:337–9.

    Article  PubMed  CAS  Google Scholar 

  67. Izzat MB, Yim APC, El-Zufari MH. A taste of Chinese medicine! Ann Thorac Surg. 1998;66:941–2.

    Article  PubMed  CAS  Google Scholar 

  68. Breithaupt-Grogler K, Ling M, Boudoulas H, et al. Protective effect of chronic garlic intake on elastic properties of aorta in the elderly. Circulation. 1997;96:2649–55.

    PubMed  CAS  Google Scholar 

  69. Koscielny J, Klussendorf D, Latza R, et al. The antiatherosclerotic effect of Allium sativum. Atherosclerosis. 1999;144:237–49.

    Article  PubMed  CAS  Google Scholar 

  70. Blum A, Porat R, Rosenschein U, et al. Clinical and inflammatory effects of dietary L-arginine in patients with intractable angina pectoris. Am J Cardiol. 1999;15:1488–90.

    Article  Google Scholar 

  71. Maxwell AJ, Zapien MP, Pearce GL, et al. Randomized trial of a medical food for the dietary management of chronic, stable angina. J Am Coll Cardiol. 2002;39:37–45.

    Article  PubMed  CAS  Google Scholar 

  72. Ceremuzynski L, Chamiec T, Herbaczynska-Cedro K. Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris. Am J Cardiol. 1997;80:331–3.

    Article  PubMed  CAS  Google Scholar 

  73. Oomen CM, van Erk MJ, Feskens E, et al. Arginine intake and risk of coronary heart disease mortality in elderly men. Arterioscler Thromb Vasc Biol. 2000;20:2134–9.

    Article  PubMed  CAS  Google Scholar 

  74. Feskens EJM, Oomen CM, Hogendoorn E, et al. Arginine intake and 25-year CHD mortality: the seven countries study (letter). Eur Heart J. 2001;22:611–2.

    Article  PubMed  CAS  Google Scholar 

  75. Venho B, Voutilainen S, Valkonen VP, et al. Arginine intake, blood pressure, and the incidence of acute coronary events in men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Clin Nutr. 2002;76:359–64.

    PubMed  CAS  Google Scholar 

  76. Hertog MG, Feskens EJ, Hollman PC, et al. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet. 1993;342:1007–11.

    Article  PubMed  CAS  Google Scholar 

  77. Aviram M, Rosenblat M, Gaitini D, et al. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin Nutr. 2004;23:423–33.

    Article  PubMed  CAS  Google Scholar 

  78. Kamikawa T, Kobayashi A, Yamashita T, et al. Effects of coenzyme Q10 on exercise tolerance in chronic stable angina pectoris. Am J Cardiol. 1985;56:247–51.

    Article  PubMed  CAS  Google Scholar 

  79. Vogel JHK, Bolling SF, Costello RB, Guarneri EM, Krucoff MW, Longhurst JC, et al. Integrating complementary medicine into cardiovascular medicine: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine). J Am Coll Cardiol. 2005;46:184–221.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Complementary and Integrative Medicine Program, Mayo Clinic, Rochester, MN, USA

    Brent A. Bauer

Authors
  1. Brent A. Bauer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brent A. Bauer .

Editor information

Editors and Affiliations

  1. College of Medicine, Mayo Clinic, First Street SW., 200, Rochester, 55905, Minnesota, USA

    Gregory W. Barsness

  2. Div. Cardiovascular Diseases, St. Mary's Hospital, Rochester, 55905, Minnesota, USA

    David R. Holmes

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag London Limited

About this chapter

Cite this chapter

Bauer, B.A. (2012). Alternative Therapies for Chronic Refractory Coronary Artery Disease. In: Barsness, G., Holmes, D. (eds) Coronary Artery Disease. Springer, London. https://doi.org/10.1007/978-1-84628-712-1_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-712-1_11

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-460-1

  • Online ISBN: 978-1-84628-712-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation